$2.92
-0.10-3.31%
Últ. Act.: Oct 23, 12:27 AM
Entera Bio (ENTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.08 | $-0.09 | $-0.09 |
| Actual | $-0.14 | $-0.07 | $-0.06 | $-0.07 |
| Surprise | -75.0% | +12.5% | +33.3% | +22.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.13 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.14 | $-0.08 | -75.0 % |
| Q1 | May 8, 2026 | $-0.07 | $-0.08 | 12.5 % |
| Q4 | Mar 27, 2026 | $-0.06 | $-0.09 | 33.3 % |
| Q3 | Nov 14, 2025 | $-0.07 | $-0.09 | 22.2 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 8, 2025 | $0 | $163.20M | -100.0 % |
| Q4 | Mar 28, 2025 | $82.00K | $40.00K | 105.0 % |
| Q3 | Nov 8, 2024 | $42.00K | $40.00K | 5.00 % |
| Q1 | May 5, 2023 | $0 | $100.00K | -100.0 % |